Stock ZENLABS6 ZENLABS ETHICA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Zenlabs Ethica Limited

Equities

ZENLABS6

INE546F01013

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 03:31:00 27/06/2024 pm IST 		5-day change 1st Jan Change
41.09 INR +0.27% Intraday chart for Zenlabs Ethica Limited +1.36% -0.75%
20/05 Zenlabs Ethica Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
29/01 Zenlabs Ethica Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

Valuation

Fiscal Period: Maart 2018 2019 2020 2021 2022 2023
Capitalization 1 322.4 375.3 237 137.7 185.5 449.6
Enterprise Value (EV) 1 318.6 364.6 231.5 147.1 209.5 491.8
P/E ratio 27.7 x 29.7 x -32.3 x 16.6 x 22.6 x 92.1 x
Yield - - - - - -
Capitalization / Revenue 0.45 x 0.56 x 0.4 x 0.24 x 0.27 x 0.67 x
EV / Revenue 0.44 x 0.54 x 0.39 x 0.26 x 0.3 x 0.74 x
EV / EBITDA 17.2 x 17.4 x -34 x 10.6 x 11.7 x 24.9 x
EV / FCF -119 x 148 x -141 x -9.62 x -25 x -145 x
FCF Yield -0.84% 0.68% -0.71% -10.4% -4% -0.69%
Price to Book 4.6 x 4.53 x 3.2 x 1.64 x 1.98 x 4.63 x
Nbr of stocks (in thousands) 6,510 6,510 6,510 6,510 6,510 6,510
Reference price 2 49.52 57.65 36.40 21.15 28.50 69.06
Announcement Date 23/05/18 03/09/19 19/11/20 04/09/21 07/09/22 06/09/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Maart 2018 2019 2020 2021 2022 2023
Net sales 1 718.4 673 599.5 566.4 690.9 668.9
EBITDA 1 18.54 20.92 -6.806 13.87 17.89 19.78
EBIT 1 16.51 18.67 -9.729 11.14 15.45 16.55
Operating Margin 2.3% 2.77% -1.62% 1.97% 2.24% 2.47%
Earnings before Tax (EBT) 1 16.54 18.9 -11.68 9.244 12.62 6.745
Net income 1 11.64 12.63 -7.327 8.319 8.225 4.893
Net margin 1.62% 1.88% -1.22% 1.47% 1.19% 0.73%
EPS 2 1.788 1.940 -1.125 1.278 1.260 0.7500
Free Cash Flow 1 -2.681 2.465 -1.646 -15.29 -8.385 -3.381
FCF margin -0.37% 0.37% -0.27% -2.7% -1.21% -0.51%
FCF Conversion (EBITDA) - 11.78% - - - -
FCF Conversion (Net income) - 19.51% - - - -
Dividend per Share - - - - - -
Announcement Date 23/05/18 03/09/19 19/11/20 04/09/21 07/09/22 06/09/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: Maart 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - 9.39 24 42.3
Net Cash position 1 3.77 10.7 5.48 - - -
Leverage (Debt/EBITDA) - - - 0.6764 x 1.339 x 2.137 x
Free Cash Flow 1 -2.68 2.47 -1.65 -15.3 -8.39 -3.38
ROE (net income / shareholders' equity) 18.2% 16.5% -9.34% 10.5% 9.17% 5.14%
ROA (Net income/ Total Assets) 3.27% 3.61% -1.77% 2.11% 2.76% 2.54%
Assets 1 356.3 350.4 415 395 298.5 192.5
Book Value Per Share 2 10.80 12.70 11.40 12.90 14.40 14.90
Cash Flow per Share 2 1.890 2.560 3.220 2.550 2.320 2.490
Capex 1 0.33 3.91 0.53 6.15 0.27 15.5
Capex / Sales 0.05% 0.58% 0.09% 1.09% 0.04% 2.31%
Announcement Date 23/05/18 03/09/19 19/11/20 04/09/21 07/09/22 06/09/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
ZENLABS ETHICA LIMITED Stock Zenlabs Ethica Limited
-0.75% 31.92L
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
+0.30% 2.46TCr
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+14.70% 875.16Cr
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+0.49% 835.23Cr
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-28.87% 710.32Cr
H. LUNDBECK A/S Stock H. Lundbeck A/S
+16.12% 524.87Cr
GALENICA AG Stock Galenica AG
+2.34% 410.4Cr
EBOS GROUP LIMITED Stock EBOS Group Limited
-8.90% 380Cr
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
-7.62% 339.34Cr
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+9.36% 325.02Cr
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. ZENLABS6 Stock
  4. Financials Zenlabs Ethica Limited